1. EMR Intercountry Workshop, December 2010 1 |1 | VP-IBD Surveillance Data, 2009 Photo: Dr. Mary Agócs

2. EMR Intercountry Workshop, December 2010 2 |2 |

3. 3 |3 | VP-IBD and Rotavirus Global and Regional Laboratory Network Structure, 2010 WHO Regional Reference Laboratories WHO Global Reference Laboratories Global: IBD & Rota Rota IBD IBD & Rota IBD Rota IBD Rota IBD

4. EMR Intercountry Workshop, December 2010 4 |4 | Countries in WHO VP-IBD Surveillance Network, by WHO Region and GAVI Eligibility, 2009 34 / 47 reporting countries are GAVI-eligible= 72%

5. EMR Intercountry Workshop, December 2010 5 |5 | Tier 1 VP-IBD Countries: Meningitis Surveillance

6. EMR Intercountry Workshop, December 2010 6 |6 | Tier 1: Meningitis Surveillance Data, 2008 Compared with 2009 India, Philippines, and Viet Nam join the network in 2009

7. AMR AFR EMR SEAR WPR EUR 22 52 49 92 29 30

8. AMR AFR EMR SEAR WPR EUR

9. EMR Intercountry Workshop, December 2010 9 |9 | % Probable Bacterial Meningitis Cases with HI, by Years of Hib Vaccine Introduction & WHO Region, 2009 (regional medians with country-specific ranges)

10. Data collected from WHO Regions and partners and WHO/IVB Database as of September 2010. Invasive Bacterial Diseases Surveillance Tier 2 Slide date: 16 September 2010 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2010. All rights reserved 16 Countries VP-IBD Surveillance: Tier 2 Meningitis-Sepsis-Pneumonia Surveillance

11. EMR Intercountry Workshop, December 2010 11 | IBD Surveillance, Tier 2 Meningitis-Sepsis-Pneumonia Numbers of reporting countries & children enrolled with pneumonia with % change from 2008 to 2009, by WHO region SEAR: increased reporting from Bangladesh & Nepal

12. EMR Intercountry Workshop, December 2010 12 | Tier 2: Meningitis-Pneumonia-Sepsis Detected Organisms, 2009

13. % serotypes in PCV-7, 10, and 13 AFR: 48%, 80%, and 91%, SEAR: and 44%, 69%, and 75%, Spn. Serotype Data, Tier 1: Meningitis

14. EMR Intercountry Workshop, December 2010 14 | Rotavirus Surveillance, 2009 Photo: Dr. Duncan Steele

15. EMR Intercountry Workshop, December 2010 15 | Rotavirus Surveillance Countries Participating in the WHO Network and Reporting Data for 2009 Data collected from WHO Regions. Slide date: 2 August 2010 Yes (55 Member States or 28% of Member States)

16. EMR Intercountry Workshop, December 2010 16 | IBD and Rotavirus Global and Regional Laboratory Network Structure, 2010 WHO Regional Reference Laboratories WHO Global Reference Laboratories Global: IBD & Rota Rota IBD IBD & Rota IBD Rota IBD Rota IBD

17. EMR Intercountry Workshop, December 2010 17 | Countries in the WHO Rotavirus Surveillance Network, by WHO Region & GAVI Eligibility, 2009 34 / 55 are GAVI-eligible= 62%

18. EMR Intercountry Workshop, December 2010 18 | Rotavirus Surveillance 2008 Compared with 2009 SEAR: Indonesia and Sri Lanka joined in 2009 NOTE: No data from the AMR countries of St. Vincent & Grenadines and Surinam.

19. EMR Intercountry Workshop, December 2010 19 | AMR AFR EMR EUR SEAR WPR

20. EMR Intercountry Workshop, December 2010 20 | % Positive for Rotavirus, WHO Regional Medians and Ranges, 2009 Country-specific Ranges (%) Median (%) No. (%) Reporting Countries WHO region 15 – 593512 (22)AFR 0 – 522514 (25)AMR 14 – 604213 (24)EMR 12 – 52376 (11)EUR 26 – 48374 (7)SEAR 24 – 68476 (11)WPR 0 – 683655 (100)TOTAL Countries using rotavirus vaccine: Bolivia, Colombia, Ecuador, El Salvador, Honduras, Nicaragua, Panama, Venezuela

21. EMR Intercountry Workshop, December 2010 21 | Genotypes, 2009 n=2,782 Countries using rotavirus vaccine: Nicaragua, El Salvador